| pubmed-article:18681749 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C0003289 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C1269683 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:18681749 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:18681749 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:18681749 | pubmed:dateCreated | 2008-9-25 | lld:pubmed |
| pubmed-article:18681749 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:abstractText | Major depressive disorder (MDD) is a severe mental illness with high risk of suicidality. Antidepressant treatment alone is not sufficient for the acute management of risk-taking symptoms of depression. This pilot study was designed to investigate the efficacy of risperidone augmentation to antidepressants in the acute management of suicidality and other core symptoms in MDD with suicidality. | lld:pubmed |
| pubmed-article:18681749 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18681749 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18681749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18681749 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18681749 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:18681749 | pubmed:issn | 1555-2101 | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:LiXiaohuaX | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:ZhangRushengR | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:MayRoberta... | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:DahlDaniel... | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:ReevesHollisH | lld:pubmed |
| pubmed-article:18681749 | pubmed:author | pubmed-author:BatraSachinS | lld:pubmed |
| pubmed-article:18681749 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18681749 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:18681749 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18681749 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18681749 | pubmed:pagination | 1228-336 | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:meshHeading | pubmed-meshheading:18681749... | lld:pubmed |
| pubmed-article:18681749 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18681749 | pubmed:articleTitle | Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. | lld:pubmed |
| pubmed-article:18681749 | pubmed:affiliation | Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, AL 35294, USA. | lld:pubmed |
| pubmed-article:18681749 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18681749 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18681749 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18681749 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18681749 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18681749 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18681749 | lld:pubmed |
